research

Identification of Febuxostat as a New Strong ABCG2 Inhibitor: Potential Applications and Risks in Clinical Situations

Authors
Publication date
1 January 2017
Publisher
'Frontiers Media SA'
Doi

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Frontiers - Publisher Connector

      redirect
      Last time updated on 15/05/2017

      Frontiers - Publisher Connector

      redirect
      Last time updated on 05/06/2019